// App-Quantinova.ai

e13575 : Development of a quantitative immunofluorescent method for analysis of nuclear and cytoplasmic p53 and p21 in circulating tumor cells (CTC) as biomarkers of response to p53-targeted therapy.

Researchers

Presenter

  • Jacky Woo

Principal Investigators

  • Weiguo Wu

  • Vladislava O. Melnikova

  • Kenna Lynn Anderes

  • Darren W. Davis

Medical Centers

  • ApoCell, Inc., Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • Bleomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved